The Framingham school nevus study: A pilot study

Archives of Dermatology

Volumn 140, Issue 5, 2004, Pages 545-551

  Oliveria, Susan A ^a   Geller, Alan C ^b   Dusza, Stephen W ^a   Marghoob, Ashfaq A ^a   Sachs, Dana ^a   Weinstock, Martin A ^c   Buckminster, Marcia ^d   Halpern, Allan C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d School Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER SCREENING; EPILUMINESCENCE MICROSCOPY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL PHOTOGRAPHY; MELANOMA; NEVUS; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MICROSCOPY; NEVUS; PHOTOGRAPHY; PILOT PROJECTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 2442659218     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.5.545     Document Type: Review

References (38)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA. 1997;277:1439-1444.
3. Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WHJ. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46:1787-1794.
4. Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed). 1986;292:1555-1559.
5. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;17:459-468.
6. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985;45:1855-1861.
7. Autier P, Boniol M, Severi G, et al. The body site distribution of melanocycic naevi in 6-7 year old European children. Melanoma Res. 2001;11:123-131.
8. English DR, Armstrong BK. Melanocytic nevi in children, I: anatomic sites and demographic and host factors. Am J Epidemiol. 1994;139:390-401.
9. Fritschi L, Green A, Solomon PJ. Sun exposure in Australian adolescents. J Am Acad Dermatol. 1992;27:25-28.
10. Harrison SL, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet. 1994;344:1529-1532.
11. Hanrahan PF, Hersey P, Menzies SW, Watson AB, D'Este CA. Examination of the ability of people to identify early changes of melanoma in computer-altered pigmented skin lesions. Arch Dermatol. 1997;133:301-311.
12. Dwyer T, Blizzzard L, Ashbolt R. Sunburn associated with increased number of nevi in darker as well as lighter skinned adolescents of northern European descent. Cancer Epidemiol Biomarkers Prev. 1995;4:825-830.
13. Green A, Siskind V, Hansen ME, Hanson L, Leech P. Melanocytic nevi in schoolchildren in Queensland. J Am Acad Dermatol. 1989;20:1054-1060.
14. Gallagher RP, Rivers JK, Yang CP, McLean DI, Coldman AJ, Silver HKB. Melanocytic nevus density in Asian, Indo-Pakistani, and white children: The Vancouver Mole Study. J Am Acad Dermatol. 1991;25:507-512.
15. Coombs BD, Sharples KJ, Cooke KR, Skegg DC, Elwood JM. Variation and covariates of the number of benign nevi in adolescents. Am J Epidemiol. 1992; 136:344-355.
16. Fritschi L, McHenry P, Green A, Mackie R, Green I, Siskind V. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol. 1994;130:599-603.
17. Green A, Siskind V, Green L. The incidence of melanocytic naevi in adolescent children in Queensland, Australia. Melanoma Res. 1995;5:155-160.
18. Luther H, Altmeyer P, Garbe C, et al. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol. 1996;132:1473-1478.
19. Gallagher RP, Rivers JK, Lee TK, Bajdik CD, McLean DI, Coldman AJ. Broadspectrum sunscreen use and the development of new nevi in white children. JAMA. 2000;283:2955-2960.
20. Siskind V, Darlington S, Green L, Green A. Evolution of melanocytic nevi on the faces and necks of adolescents: a four year longitudinal study. J Invest Dermatol. 2002;118:500-504.
21. Greene MH, Clark WH Jr, Tucker MA, et al. Medical intelligence: current concepts: acquired precursors of cutaneous malignant melanoma. N Engl J Med. 1985;312:91-97.
22. Clark WH Jr, Elder DE, Guerry IVD, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147-1165.
23. Rivers JK, MacLennan R, Kelly JW, et al. The Eastern Australian Childhood Nevus Study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol. 1995;32:957-963.
24. Banuls J, Climent JM, Sanchez-Paya J, Botella R. The association between idiopathic scoliosis and the number of acquired melanocytic nevi. J Am Acad Dermatol. 2001;45:35-43.
25. Coleman WP III, Gately LE III, Krementz AB, Reed RJ, Krementz ET. Nevi, lentigines, and melanomas in blacks. Arch Dermatol. 1980;116:548-551.
26. Darlington S, Siskind V, Green L, Green A. Longitudinal study of melanocytic nevi in adolescents. J Am Acad Dermatol. 2002;46:715-722.
27. Kopf AW, Levine LJ, Rigel DS, Friedman RJ, Levenstein M. Prevalence of congenital-nevus-like nevi, nevi spili, and cafe au lait spots. Arch Dermatol. 1985;121:766-769.
28. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
29. Elder DE, Clark WH Jr, Elenitsas R, Guerry D IV, Halpern AC. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol. 1993;10:18-35.
30. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol. 2001;45:260-276.
31. Marghoob AA, Kopf AW. Melanoma risk in individuals with clinically ayptical nevi. Dermatopathol Pract Concept. 1996;1:254-261.
32. Braun RP, Calza AM, Krischer J. The use of digital dermoscopy for the follow-up of congenital nevi: a pilot study. Pediatr Dermatol. 2001;18:277-281.
33. Kittler H, Seltenheim M, Dawid M, Pehamberger H, Wolff K, Binder M. Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol. 2000;136:316-320.
34. Seidenari S, Pellacani G. Surface microscopy features of congenital nevi. Clin Dermatol. 2002;20:263-267.
35. Lorenz S, Maier C, Segerer H, Landthaler M, Hohenleutner U. Skin changes in newborn infants in the first 5 days of life. Hautarzt. 2000;51:396-400.
36. Walton RG, Jacob AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol. 1976;95:389-396.
37. Rhodes AR, Albert LS, Weinstock MA. Congenital nevomelanocytic nevi: proportionate area expansion during infancy and early childhood. J Am Acad Dermatol. 1996;34:51-62.
38. English DR, Armstrong BK. Metanoctyic nevi in children, II: observer variation in counting nevi. Am J Epidemiol. 1994;139:402-407.